The Chemical Data

Marketing Authorization Application for Gadoquatrane Submitted in Japan

Marketing Authorization Application for Gadoquatrane Submitted in Japan Bayer has officially submitted a marketing authorization application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for gadoquatrane, its investigational gadolinium-based contrast agent designed for use in magnetic resonance imaging (MRI).…

Read MoreMarketing Authorization Application for Gadoquatrane Submitted in Japan

Germany’s Shisha Market Poised for Rapid Growth as 83% of Hospitality Venues Forecast Surge

Germany’s Shisha Market Set for Rapid Expansion as Hospitality Sector Embraces Innovation Market The hospitality sector in Germany is on the brink of a transformative shift as demand for shisha continues to climb at an unprecedented pace. According to new…

Read MoreGermany’s Shisha Market Poised for Rapid Growth as 83% of Hospitality Venues Forecast Surge

FDA Grants Priority Review to Sevabertinib (BAY 2927088) for Treating HER2-Mutant Non-Small Cell Lung Cancer

Bayer’s Sevabertinib (BAY 2927088) Receives FDA Priority Review for HER2-Mutant Non-Small Cell Lung Cancer FDA Bayer has announced that its investigational compound, sevabertinib (BAY 2927088), has been granted Priority Review status by the U.S. Food and Drug Administration (FDA) for…

Read MoreFDA Grants Priority Review to Sevabertinib (BAY 2927088) for Treating HER2-Mutant Non-Small Cell Lung Cancer

Wacker Biotech and Expression Manufacturing Partner to Boost Lentiviral Gene & Cell Therapy Development

Wacker Biotech US and Expression Manufacturing Forge Strategic Alliance to Accelerate Lentiviral Vector Development for Next-Generation Gene Therapies Wacker Biotech In an era marked by rapid advancements in gene and cell therapies, the demand for high-quality, scalable lentiviral vectors has…

Read MoreWacker Biotech and Expression Manufacturing Partner to Boost Lentiviral Gene & Cell Therapy Development